Your fact-checks will appear here
Heart failure is a condition where isosorbide may be used.
(AF) occurring with (RVR) in patients who already have with reduced ejection fraction (HFrEF) is linked to substantially worse outcomes: new AF in HFrEF raises all‑cause mortality risk markedly (hazar...
is a class of nitrate drugs—most commonly isosorbide mononitrate and isosorbide dinitrate—used primarily to prevent (heart-related chest pain) by dilating blood vessels and lowering the heart’s worklo...
is an angiotensin‑converting enzyme (ACE) inhibitor commonly prescribed to treat high blood pressure, , and to improve survival after a heart attack; it relaxes blood vessels by blocking production of...
(VEDs) pose a plausible increased bleeding risk for patients on systemic anticoagulation, but high-quality, device-specific quantitative data are scarce; the literature is limited to small series and ...
Dual GIP/GLP‑1 agonists like tirzepatide reduce weight and improve multiple cardiometabolic risk factors that plausibly lower heart‑failure events in obese patients, particularly HFpEF, via hemodynami...
Ferritin measures stored iron but is also an acute-phase reactant, so elevated ferritin can reflect inflammation, liver disease, or other non‑iron causes and therefore mislead clinicians about true ir...